Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

Eun-Kee Song

Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

Eun-Kee Song

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Cancer Research and Treatment
State	Published - 2017.01.6

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{dec4988d3f6d45c583d1ca4207b28bc7,

title = "Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study",

author = "Eun-Kee Song",

year = "2017",

month = jan,

day = "6",

language = "Korean",

journal = "Cancer Research and Treatment",

issn = "1598-2998",

}

Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study. / Song, Eun-Kee.
In: Cancer Research and Treatment, 06.01.2017.

Research output: Contribution to journal › Journal article › peer-review

TY - JOUR

T1 - Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

AU - Song, Eun-Kee

PY - 2017/1/6

Y1 - 2017/1/6

M3 - Journal article

SN - 1598-2998

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

ER -